Trial Profile
Phase I trial of Vical's cytomegalovirus vaccine (VCL CB01) in volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Jul 2008
Price :
$35
*
At a glance
- Drugs VCL CB01 (Primary)
- Indications Cytomegalovirus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Vical
- 02 Jul 2008 New trial record.